Evidence map›Paper›PMID 23880518›Full record

ArticleEpigenetics2013

E2f6-mediated repression of the meiotic Stag3 and Smc1β genes during early embryonic development requires Ezh2 and not the de novo methyltransferase Dnmt3b.

Milena Leseva, Katherine E Santostefano, Amy L Rosenbluth, Takashi Hamazaki, Naohiro Terada

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Frontiers in immunology · 2025
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Regulation and Role of EZH2 in Cancer.Cancer research and treatment · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Milena LesevaDepartment of Pathology; University of Florida College of Medicine; Gainesville, FL USA.
Katherine E Santostefano
Amy L Rosenbluth
Takashi Hamazaki
Naohiro Terada
University of Florida · US

Funding

Developing Male Contraceptives by Targeting ANT4U01HD060474 · NICHD · UNIVERSITY OF FLORIDA · PI TERADA, NAOHIRO · 2009 to 2013
$1.2M
iPSC Generation using Peptide Injection and Site-Selective HDAC InhibitionRC1GM091238 · NIGMS · UNIVERSITY OF FLORIDA · PI HAMAZAKI, TAKASHI, JIN, SHOUGUANG · 2009 to 2010
$965k
NICHD NIH HHS HD060474NICHD NIH HHS U01 HD060474NIGMS NIH HHS GM091238NIGMS NIH HHS RC1 GM091238
6 · The paper itself

Abstract

The E2f6 transcriptional repressor is an E2F-family member essential for the silencing of a group of meiosis-specific genes in somatic tissues. Although E2f6 has been shown to associate with both polycomb repressive complexes (PRC) and the methyltransferase Dnmt3b, the cross-talk between these repressive machineries during E2f6-mediated gene silencing has not been clearly demonstrated yet. In particular, it remains largely undetermined when and how E2f6 establishes repression of meiotic genes during embryonic development. We demonstrate here that the inactivation of a group of E2f6 targeted genes, including Stag3 and Smc1β, first occurs at the transition from mouse embryonic stem cells (ESCs) to epiblast stem cells (EpiSCs), which represent pre- and post-implantation stages, respectively. This process was accompanied by de novo methylation of their promoters. Of interest, despite a clear difference in DNA methylation status, E2f6 was similarly bound to the proximal promoter regions both in ESCs and EpiSCs. Neither E2f6 nor Dnmt3b overexpression in ESCs decreased meiotic gene expression or increased DNA methylation, indicating that additional factors are required for E2f6-mediated repression during the transition. When the SET domain of Ezh2, a core subunit of the PRC2 complex, was deleted, however, repression of Stag3 and Smc1β during embryoid body differentiation was largely impaired, indicating that the event required the enzymatic activity of Ezh2. In addition, repression of Stag3 and Smc1β occurred in the absence of Dnmt3b. The data presented here suggest a primary role of PRC2 in E2f6-mediated gene silencing of the meiotic genes.

Indexed as

AnimalsCell Cycle ProteinsDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDNA Methyltransferase 3BE2F6 Transcription FactorEmbryonic DevelopmentEmbryonic Stem CellsEnhancer of Zeste Homolog 2 ProteinGene SilencingGerm LayersMeiosisMiceMice, KnockoutNuclear ProteinsPolycomb Repressive Complex 2Cell Cycle ProteinsDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BE2f6 protein, mouseE2F6 Transcription FactorEnhancer of Zeste Homolog 2 ProteinEzh2 protein, mouseNuclear ProteinsPolycomb Repressive Complex 2Smc1l2 protein, mouseStag3 protein, mouseDNA methylationE2f6embryonic developmentEzh2germline genesstem cellstranscriptional silencing

Identifiers

PMID23880518
PMCPMC3883790
OpenAlexW2062796748

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.